When the Lyme Disease Association Inc. (LDA) was contacted by a student at Duke Law who wanted to organize a group of students in a Lyme disease pro bono project, I was very excited about the possibilities…Lyme is not just a disease but a political nightmare… this was an opportunity to have some of the brightest and most motivated of our youth tackle this epidemic….The findings from this group of law students can be disseminated and used to empower patients, families, physicians, politicians, and researchers to unravel the secrets surrounding Lyme and provide solutions for Lyme and other tick-borne diseases across the globe.
Search Results for: vaccines
Hassan Hakimi, et al., published “Advances in understanding red blood cell modifications by Babesia,” in PLOS Pathogens on September 15, 2022, to further investigate how the parasite invades and multiplies within red blood cells (RBCs) of mammalian hosts.
An article in Martha Vineyard Times announced that phase 3 trials for the Valneva-Pfizer Lyme disease vaccine candidate, VLA15, will take place on the Vineyard. This trial phase will investigate the extent to which the vaccine provides protection.
According to a new study conducted by Swedish researchers at Lund University, the messenger RNA (mRNA) from Pfizer’s COVID-19 vaccine is able to enter human liver where it triggers the […]
The FDA has just announced that they plan to postpone their scheduled advisory committee meeting on Pfizer’s COVID-19 vaccine for children ages 6 months to 4 years. They do not […]
In a February 4, 2022 news release Valneva/Pfizer reported positive Phase 2 data findings for their Lyme disease vaccine candidate, VLA15. According to the news release, findings of the Phase […]
A new peer reviewed article was published in Cureus that evaluated the use of Ivermectin for prophylaxis of COVID 19 in a city-wide study conducted in Itajaí, Brazil. Study results […]